AI assistant
BIO-TECHNE Corp — Director's Dealing 2023
Aug 17, 2023
30718_dirs_2023-08-17_d5ca6a17-5c72-4863-acb3-8105edbf3d75.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2023-08-15
Reporting Person: Kelderman Kim (Pres. Diagnostics & Genom)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-08-15 | Restricted Stock Units | $ | A | 8191 | Acquired | Common Stock (8191) | Direct | |
| 2023-08-15 | Stock Options (Right to Buy) | $84.61 | A | 22043 | Acquired | 2030-08-15 | Common Stock (22043) | Direct |
| 2023-08-15 | Stock Options (Right to Buy) | $84.61 | A | 29391 | Acquired | 2030-08-15 | Common Stock (29391) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 19125 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $37.70 | 2025-05-01 | Common Stock (27392) | 27392 | Direct |
| Stock Option (Right to Buy) | $44.33 | 2025-08-08 | Common Stock (48176) | 48176 | Direct |
| Stock Option (Right to Buy) | $44.33 | 2025-08-08 | Common Stock (36132) | 36132 | Direct |
| Stock Option (Right to Buy) | $47.60 | 2026-08-07 | Common Stock (47844) | 47844 | Direct |
| Stock Option (Right to Buy) | $47.60 | 2026-08-07 | Common Stock (63792) | 63792 | Direct |
| Stock Option (Right to Buy) | $66.97 | 2027-08-05 | Common Stock (35964) | 35964 | Direct |
| Stock Option (Right to Buy) | $66.97 | 2027-08-05 | Common Stock (33300) | 33300 | Direct |
| Restricted Stock Units | $ | Common Stock (8060) | 0 | Direct | |
| Stock Option (Right to Buy) | $66.97 | 2027-08-05 | Common Stock (47952) | 47952 | Direct |
| Restricted Stock Units | $ | Common Stock (4980) | 4980 | Direct | |
| Stock Option (Right to Buy) | $120.46 | 2028-08-06 | Common Stock (19456) | 19456 | Direct |
| Stock Option (Right to Buy) | $120.46 | 2028-08-06 | Common stock (25944) | 25944 | Direct |
| Restricted Stock Units | $ | Common Stock (6984) | 6984 | Direct | |
| Stock Options (Right to Buy) | $94.52 | 2029-08-15 | Common Stock (21704) | 21704 | Direct |
| Stock Options (Right to Buy) | $94.52 | 2029-08-15 | Common Stock (28940) | 28940 | Direct |
Footnotes
F1: Fully exercisable.
F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F3: On 8/5/2023, the Board of Directors certified vesting of 8,060 performance RSUs.
F4: Options to purchase 11,988 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024.
F5: Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F6: Options to purchase 12,972 shares are vested. Options to purchase 6,488 shares vest on 8/6/2024 and options to purchase 6,484 shares vest on 8/6/2025.
F7: Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8: Options to purchase 7,236 shares vest on each of 8/15/2023, 8/15/2024 and 8/15/2026 and options to purchase 7,232 shares vest on 8/15/2025.
F9: Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F10: Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026.